This company has been marked as potentially delisted and may not be actively trading. Vital Therapies (VTL) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock VTL vs. PROC, OPTN, VIRI, WHWK, VHAQ, PYRGF, OSTX, AADI, NBRV, and ATNMShould you be buying Vital Therapies stock or one of its competitors? The main competitors of Vital Therapies include Procaps Group (PROC), OptiNose (OPTN), Virios Therapeutics (VIRI), Whitehawk Therapeutics (WHWK), Viveon Health Acquisition (VHAQ), PyroGenesis Canada (PYRGF), OS Therapies (OSTX), Aadi Bioscience (AADI), Nabriva Therapeutics (NBRV), and Actinium Pharmaceuticals (ATNM). Vital Therapies vs. Its Competitors Procaps Group OptiNose Virios Therapeutics Whitehawk Therapeutics Viveon Health Acquisition PyroGenesis Canada OS Therapies Aadi Bioscience Nabriva Therapeutics Actinium Pharmaceuticals Vital Therapies (NASDAQ:VTL) and Procaps Group (NASDAQ:PROC) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, earnings, media sentiment, institutional ownership, analyst recommendations, profitability, dividends and risk. Which has preferable valuation & earnings, VTL or PROC? Procaps Group has higher revenue and earnings than Vital Therapies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVital TherapiesN/AN/A-$41.47MN/AN/AProcaps Group$409.92M0.26$42.54MN/AN/A Which has more volatility and risk, VTL or PROC? Vital Therapies has a beta of 3.51, meaning that its stock price is 251% more volatile than the S&P 500. Comparatively, Procaps Group has a beta of -0.05, meaning that its stock price is 105% less volatile than the S&P 500. Does the media favor VTL or PROC? In the previous week, Vital Therapies' average media sentiment score of 0.00 equaled Procaps Group'saverage media sentiment score. Company Overall Sentiment Vital Therapies Neutral Procaps Group Neutral Is VTL or PROC more profitable? Procaps Group's return on equity of 0.00% beat Vital Therapies' return on equity.Company Net Margins Return on Equity Return on Assets Vital TherapiesN/A -235.33% -182.35% Procaps Group N/A N/A N/A Do insiders and institutionals hold more shares of VTL or PROC? 15.5% of Vital Therapies shares are owned by institutional investors. 33.9% of Vital Therapies shares are owned by insiders. Comparatively, 19.9% of Procaps Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. SummaryProcaps Group beats Vital Therapies on 4 of the 7 factors compared between the two stocks. Get Vital Therapies News Delivered to You Automatically Sign up to receive the latest news and ratings for VTL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VTL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VTL vs. The Competition Export to ExcelMetricVital TherapiesPharmaceutical Preparations IndustryMedical SectorNASDAQ ExchangeMarket Cap$30.81M$798.01M$5.53B$9.02BDividend YieldN/A4.84%5.22%3.99%P/E RatioN/A1.3727.7920.25Price / SalesN/A230.41430.22119.26Price / CashN/A23.4426.2128.59Price / Book2.516.328.035.65Net Income-$41.47M-$27.99M$3.18B$249.15M Vital Therapies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VTLVital TherapiesN/A$0.73+2.0%N/A-32.7%$30.81MN/A0.0010PROCProcaps GroupN/A$0.95-40.3%N/A-62.0%$107.18M$409.92M0.004,900Gap DownHigh Trading VolumeOPTNOptiNose0.7205 of 5 stars$9.60flat$9.00-6.3%N/A$97.22M$81.86M-2.29190VIRIVirios TherapeuticsN/A$4.77+1.3%$5.00+4.8%+1,977.0%$91.86MN/A-17.675WHWKWhitehawk TherapeuticsN/A$1.86-0.5%N/AN/A$87.63M$25.98M11.6340VHAQViveon Health AcquisitionN/A$11.00flatN/AN/A$62.26MN/A0.002High Trading VolumePYRGFPyroGenesis Canada0.0894 of 5 stars$0.33+0.9%N/A-41.0%$62.17M$9.14M-5.5590OSTXOS Therapies2.8217 of 5 stars$1.93+2.7%$18.00+832.6%N/A$54.23MN/A-2.24N/AGap UpAADIAadi Bioscience0.6388 of 5 stars$1.87-3.1%$1.67-10.9%+49.6%$46.18M$25.07M-0.8240NBRVNabriva TherapeuticsN/AN/AN/AN/A$45.46M$35.59M0.0070ATNMActinium Pharmaceuticals2.807 of 5 stars$1.35-3.6%$4.00+196.3%N/A$42.12M$81K-0.9730Positive News Related Companies and Tools Related Companies PROC Competitors OPTN Competitors VIRI Competitors WHWK Competitors VHAQ Competitors PYRGF Competitors OSTX Competitors AADI Competitors NBRV Competitors ATNM Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VTL) was last updated on 7/7/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vital Therapies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vital Therapies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
